Aging Clinical Trial
— CogExOfficial title:
A Precision Rehabilitation Approach to Counteract Age-Related Cognitive
Verified date | March 2023 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study examines the behavioral, molecular, and structural biomarkers of brain health that will allow for the stratification of individuals according to their "cognitive signature" and function. This study will randomize older adults into one of four interventions for a period of 12 months: 1) Aerobic Exercise, 2) Resistance Exercise, 3) Yoga Exercise, 4) Health Education (involves stretching and range of motion activities). This aims of this study will examine whether and how these different types of training interventions exert effects cognitive function, brain structure, biomarkers of brain health and cognition, and physical function.
Status | Terminated |
Enrollment | 78 |
Est. completion date | December 31, 2022 |
Est. primary completion date | January 31, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age 65-80 years. 2. Sedentary, which is defined as regular participation over the past 3 months in <60 minutes per week of moderate-to-vigorous leisure-time or transportation-related physical activity performed in bouts of >10 minutes. 3. Independent ambulation without or with an cane or walking stick. 4. Able to walk (with or without assistive device such as a cane or walking stick) a distance of at least 400 meters based on self-report. 5. The ability to provide clearance from a physician for participation in the assessments and intervention aspects of this study. 6. Ability to provide informed consent. Exclusion Criteria: 1. Reporting engaging in regular aerobic exercise, resistance exercise, or yoga exercise over the prior 3 months. 2. History of stroke, uncontrolled resting hypertension (systolic blood pressure =150 mmHg or diastolic blood pressure =100 mmHg), congestive heart failure, recent myocardial infarction, or other contraindications to engagement in moderate-intensity physical activity for at least 10 continuous minutes. 3. Incompatibility with the MRI environment (e.g. claustrophobia, metal implants, or body size, etc.) 4. Inability to attend the sessions as prescribed. 5. Consuming >1 alcoholic drink per day on >4 days per week, or current treatment for substance use disorder. 6. Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance to at least 80 percent of the scheduled intervention sessions and all of the scheduled assessments. 7. Use of a walker or rolling walker for ambulation. 8. SPPB score of <6 or unable to perform any of the 3 components of the total score [item score = 0]. 9. Inability to complete the 400m walk test; or an unhealthy response to test [e.g., Systolic blood pressure >240 or diastolic blood pressure >115; or a drop in diastolic blood pressure > 10mm]. 10. Depressive symptoms not controlled or treated. 11. List the medications that will exclude a participant (e.g., those that may complicate brain imaging, cognitive test, or biomarker testing or interpretation). 12. Degenerative neurological condition [e.g., Parkinson's Disease, multiple sclerosis]. 13. Severe respiratory disease [eg COPD with shortness of breath], or use of supplemental oxygen. 14. Lower limb below or above knee amputation / prosthesis. 15. Score of <85 of the 3MS (Modified Mini-Mental State Exam). |
Country | Name | City | State |
---|---|---|---|
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change from Baseline subjective well-being at 3, 6, and 12 months | Measured by the Satisfaction with Life Scale (SWLS) 5-item questionnaire | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Mood at 3, 6, and 12 months | Measured by the Positive and Negative Affect Schedule (PANAS) questionnaire | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Self-Efficacy for Physical Activity at 3, 6, and 12 months | Measured by questionnaire with higher scores indicating greater self-efficacy | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Physical Activity Outcome Expectations at 3, 6, and 12 months | Measured by questionnaire with higher scores indicating great outcome expectations. | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Physical Activity Barriers at 3, 6, and 12 months | Measured by questionnaire with higher scores indicating greater barriers. | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Social Support for Physical Activity at 3, 6, and 12 months | Measured by questionnaire with higher scores indicating greater social support | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Weight in kilograms at 3, 6, and 12 months | Measured using a digital scale | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline Height in centimeters at 3, 6, and 12 months | Measured using a wall-mounted stadiometer | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline resting systolic and diastolic blood pressure in mmHg at 3, 6, and 12 months | Measured using an automated blood pressure system | Baseline, 3 months, 6 months, 12 months | |
Other | Change from Baseline resting heart rate in beats per minute at 3, 6, and 12 months | Measured using an automated system | Baseline, 3 months, 6 months, 12 months | |
Primary | Change from Baseline Brain Structure at 6 and 12 months | Measured used MRI and fMRI tasks. | Baseline, 6 months, 12 months | |
Secondary | Change from Baseline Functional Fitness at 3, 6, and 12 months | Assessed with the Short Physical Performance Battery | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Fitness at 3, 6, and 12 months | Assessed with a 400 meter corridor walk. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Repeatable Battery for the Assessment of Neuropsychological Status at 3, 6, and 12 months | This is a brief standardized paper-and-pencil neurocognitive battery measuring immediate and delayed memory, attention, language, and visuospatial skills. The test comprises of 12 subtests that is administered by a trained examiner. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Modified Mini-Mental Status Exam at 3, 6, and 12 months | This is an expanded 100-point version of the original Mini-Mental Status Exam, administered in ~7 minutes, which assesses global cognitive function. This measure has very good reliability, validity, and sensitivity to moderate cognitive changes and has a proven record in clinical trials. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Auditory Verbal Learning Test at 3, 6, and 12 months | The participant is read a list of 15 words, 5 times. After each time, the participant is asked to immediately recall as many words as possible. Following the 5th recall, an interference list is presented, after which the participant is asked to spontaneously recall words from the original list. After a 10-minute interval has passed, the participant is asked again to recall as many words as possible from the original list. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Physical Activity (minutes per week) at 3, 6, and 12 months | Measured by Actigraphy | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Physical Activity (minutes per week) at 3, 6, and 12 months | Measured by CHAMPS questionnaire. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Physical Activity (minutes per week) at 3, 6, and 12 months | Measured by Paffenbarger questionnaire. | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Sedentary Behavior (minutes per day) at 3, 6, and 12 months | Measured by modified CARDIA questionnaire | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Sedentary Behavior (minutes per day) at 3, 6, and 12 months | Measured by Actigraphy | Baseline, 3 months, 6 months, 12 months | |
Secondary | Change from Baseline Peripheral biomarkers at 3, 6, and 12 months | Assessed from venous blood collection and includes measures of neuroinflammation, neurogenesis, and cerebral vascularity | Baseline, 3 months, 6 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Recruiting |
NCT06032065 -
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD)
|
Phase 3 | |
Completed |
NCT05293730 -
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
|
N/A | |
Recruiting |
NCT03932162 -
Gene Expression Changes In Young and Geriatric Skin
|
Early Phase 1 | |
Completed |
NCT04064528 -
Effects of Age on Amino Acid Delivery to Tendon
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT06029920 -
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT05566938 -
Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly
|
N/A | |
Recruiting |
NCT05543980 -
Leg Heat Therapy in Elderly Individuals
|
Phase 2 | |
Completed |
NCT04894929 -
Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement
|
N/A | |
Not yet recruiting |
NCT06071130 -
Emotion, Aging, and Decision Making
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT04088006 -
The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity
|
N/A | |
Completed |
NCT03695081 -
Patient Pathway Pharmacist - Optimal Drug-related Care
|
N/A | |
Recruiting |
NCT05424263 -
Acetate and Age-associated Arterial Dysfunction
|
Phase 2 | |
Completed |
NCT05601713 -
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
|
N/A | |
Completed |
NCT04551339 -
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19
|
N/A | |
Recruiting |
NCT04997577 -
Speech Perception and High Cognitive Demand
|
N/A | |
Completed |
NCT05922475 -
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
|
N/A | |
Completed |
NCT04015479 -
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults
|
N/A |